Lifestyle

Virtual lung cancer screening is as effective as face-to-face screening

Implementation of a new single-encounter telemedicine lung cancer screening (SET-LCS) in Covid-19 will maintain access among African Americans. Credit: American College of Surgeons

According to a study published at the American College of Surgeons (ACS), a new telemedicine lung cancer screening effort during the COVID-19 pandemic is as effective as a virtual single-visit screening performed directly in a hospital. It shows that it is a target. Virtual Clinical Congress 2021.

Virtual research lung cancer Screening (LCS) was conducted at Temple University Hospital in Philadelphia, which has a large number of African-American patients. African Americans face inequality, especially in the treatment of lung cancer. They are less likely to be screened and treated for lung cancer and more likely to die of lung cancer than lung cancer. General populationJessica S. Magalinos, MD, a general surgeon at Temple University Hospital and lead author of the study, explained. The authors hypothesized that the LCS inequality would worsen during COVID-19, but she said it was not.

“Our study shows that telemedicine screening was able to reach the African-American population at Safetynet Hospital,” Dr. Magalinos reported.

More People Need to Be Screened for Lung Cancer

Every year, more people die of lung cancer than any other type of cancer. Lung cancer can be treated well if detected early enough, but only about 3-6% of the population targeted for LCS is screened, says Cherie P. Erkmen, MD, a thoracic surgeon and principal investigator at Temple University Hospital. , FACS says. For retrospective studies.

“Overall, we do the sad job of getting people to undergo lung cancer screening,” said Dr. Elkmen. “Finding new ways to screen people can reduce deaths from preventable lung cancer.”

With the advent of the COVID-19 pandemic, many patients have decided to postpone lung cancer screening based on advice from scientific advisory groups such as the US Thoracic Medical College (CHEST). The authors at Temple University in Philadelphia have decided to quickly pivot to provide telemedicine lung cancer screening that reduces the risk of exposure to the COVID-19 virus. Earlier this year, ACS was one of the leading medical institutions calling on patients not to miss a cancer screening with COVID-19.

Details of the study

Researchers have found 673 patients who underwent a single-visit lung cancer screening (LCS) prior to the COVID-19 pandemic and a single-encounter telemedicine lung cancer screening (SET-) since March 2020, when the pandemic began to occur. We compared 440 patients who underwent LCS).Shutdown in the US

For the LCS population, the author retrospectively analyzed the data collected prospectively from before February 2021.For both groups, they examined race, smoking history, educational background, lung-RADS*, Cancer diagnosis and stage, and follow-up compliance using chi-square test and Fisher’s exact test.

Jessica S. Magalinos, MD, a general surgeon and lead author of the study at Temple University Hospital, and Sherry P. Elkmen, MD, a thoracic surgeon and principal investigator at Temple University Hospital, will explain the findings. Credit: American College of Surgeons

Investigation result

The racial distribution of patients before and after COVID-19 did not differ significantly. In each case, the largest group of patients screened were African-Americans (52 percent before and 37 percent later), said Dr. Magalinos. Smoking history was very different. Sixty-five percent of those screened before COVID-19 were active smokers, compared to 33% after COVID-19.

The authors concluded that there was no significant difference in the distribution of Lung-RAD results (single visit and telemedicine).

  • Lungs-RADS1, 46.4% vs. 37.0%
  • Lungs-RADS2, 44.0% vs. 50.8%
  • Lungs-RADS3, 5.3% vs. 7.6%
  • Lungs-RADS4, 4.2% vs. 4.8%
  • Lungs-RADS0, 0.1% vs 0.2%
  • CT-guided biopsy, 0.4% vs. 0.5%
  • EBUS-guided biopsy, 0.3% vs. 0.5%
  • Surgery 2.5% vs 1.1%
  • Reduced diagnostic work, 0.3% vs. 0.2%
  • Death before diagnostic work, 0% vs 0.2%

The authors also concluded that there was no significant difference in the frequency of cancer diagnosis procedures. Based on these findings, researchers conclude that telemedicine screening is as effective as face-to-face screening.

According to the authors, the telemedicine approach allowed many patients to be screened for lung cancer, but the overall number of people screened for lung cancer during the pandemic was reduced by 75%.

Dr. Elkmen wants telemedicine to continue lung cancer Post-pandemic screening will remove some barriers to screening and result in more people being screened.

The authors believe that telemedicine screening can also be applied to other types of cancer, including screening for breast and colorectal cancer, Dr. Magalinos said.


2021 USPSTF Guidance Expands Eligibility for Lung Cancer Screening


Quote: Virtual lung cancer screening is a face-to-face screening obtained from https://medicalxpress.com/news/2021-10-virtual-lung-cancer-screening-effective.html on October 24, 2021 (October 24, 2021). As effective as a day).

This document is subject to copyright. No part may be reproduced without written permission, except for fair transactions for personal investigation or research purposes. The content is provided for informational purposes only.



Virtual lung cancer screening is as effective as face-to-face screening

Source link Virtual lung cancer screening is as effective as face-to-face screening

Show More

Related Articles

Back to top button